Explore
Validate
Learn
Western blot
Immunocytochemistry
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations
- Western blot [3]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN513817 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Bone Marrow Stromal Cell Antigen 2 (BST2) (AA 1-180), (full length) antibody
- Antibody type
- Polyclonal
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 1-180, full length
- Vial size
- 50 μg
- Storage
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
- Handling
- Aliquot to avoid repeated freezing and thawing.
Submitted references Tetherin is an exosomal tether.
The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Binding Domain and Can Be Blocked by GP1-Specific Antibodies.
Lack of adaptation to human tetherin in HIV-1 group O and P.
Tethered virions are intermediates in the assembly and release of HIV-1 particles.
HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment.
Tetherin restricts productive HIV-1 cell-to-cell transmission.
Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal.
Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration.
HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes.
Edgar JR, Manna PT, Nishimura S, Banting G, Robinson MS
eLife 2016 Sep 22;5
eLife 2016 Sep 22;5
The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Binding Domain and Can Be Blocked by GP1-Specific Antibodies.
Brinkmann C, Nehlmeier I, Walendy-Gnirß K, Nehls J, González Hernández M, Hoffmann M, Qiu X, Takada A, Schindler M, Pöhlmann S
Journal of virology 2016 Dec 15;90(24):11075-11086
Journal of virology 2016 Dec 15;90(24):11075-11086
Lack of adaptation to human tetherin in HIV-1 group O and P.
Yang SJ, Lopez LA, Exline CM, Haworth KG, Cannon PM
Retrovirology 2011 Sep 28;8:78
Retrovirology 2011 Sep 28;8:78
Tethered virions are intermediates in the assembly and release of HIV-1 particles.
Karetnikov A, Suomalainen M
Virology 2010 Nov 25;407(2):289-95
Virology 2010 Nov 25;407(2):289-95
HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment.
Hauser H, Lopez LA, Yang SJ, Oldenburg JE, Exline CM, Guatelli JC, Cannon PM
Retrovirology 2010 Jun 7;7:51
Retrovirology 2010 Jun 7;7:51
Tetherin restricts productive HIV-1 cell-to-cell transmission.
Casartelli N, Sourisseau M, Feldmann J, Guivel-Benhassine F, Mallet A, Marcelin AG, Guatelli J, Schwartz O
PLoS pathogens 2010 Jun 17;6(6):e1000955
PLoS pathogens 2010 Jun 17;6(6):e1000955
Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal.
Lopez LA, Yang SJ, Hauser H, Exline CM, Haworth KG, Oldenburg J, Cannon PM
Journal of virology 2010 Jul;84(14):7243-55
Journal of virology 2010 Jul;84(14):7243-55
Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration.
Gupta RK, Mlcochova P, Pelchen-Matthews A, Petit SJ, Mattiuzzo G, Pillay D, Takeuchi Y, Marsh M, Towers GJ
Proceedings of the National Academy of Sciences of the United States of America 2009 Dec 8;106(49):20889-94
Proceedings of the National Academy of Sciences of the United States of America 2009 Dec 8;106(49):20889-94
HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes.
Iwabu Y, Fujita H, Kinomoto M, Kaneko K, Ishizaka Y, Tanaka Y, Sata T, Tokunaga K
The Journal of biological chemistry 2009 Dec 11;284(50):35060-72
The Journal of biological chemistry 2009 Dec 11;284(50):35060-72
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
